Teleflex to present at Social Media and Critical Care Conference (SMACC) in Dublin, Ireland
June 10 2016 - 6:45AM
Business Wire
Teleflex Incorporated (NYSE: TFX), a leading global provider
of medical devices for critical care, urology and surgery, is
committed to connecting clinicians with technology in a way that
improves clinical practice and advances patient outcomes. Teleflex
will present its innovative intraosseous vascular access system,
products for rescue airway, atomization and intubation needs at the
first Social Media and Critical Care Conference (“SMACC”) in
Dublin, Ireland on June 13-16, 2016.
During the event, Teleflex will be part of a global critical
care community that has grown from strong social media connections
among the delegates aiming at excellence in patient care,
innovation, teaching and learning. Teleflex will showcase its
Arrow® EZ-IO® Intraosseous Vascular Access System and other
products for rescue airway, atomization and intubation needs, host
a procedural lab and provide lectures at its booth.
The Arrow® EZ-IO® Intraosseous Vascular Access System from
Teleflex is an innovative and complete solution for rapid vascular
access – whether the emergency responder is facing difficult
vascular access challenges or the need for fast intraosseous access
for critical situations and life-threatening emergencies. This
system is designed to provide the medical professional vascular
access to the central circulation system within seconds1,
delivering medications, intravenous fluids and blood products to
adult and pediatric patients alike.
Teleflex will be sponsoring a procedural lab in partnership with
the American College of Emergency Physicians and SMACC.
Resuscitation of the critically ill is paramount for optimal
patient care and outcome, yet it can be the most stressful and
frustrating component of clinical practice. Resuscitation demands
excellence in the provision of quality invasive procedures,
however, the skills that are required to save a life are often not
utilized in a timely, optimal fashion due to lack of practice,
unfamiliarity with the procedure itself or advances in equipment or
technique. At this procedural lab, internationally renowned
instructors will be teaching utilizing actual tissue, making this a
low stress learning environment.
The Teleflex Clinical & Medical Affairs team will be at the
booth to provide lectures on the latest clinical topics and
resuscitation scenarios using high fidelity simulation models in a
virtual reality environment. The team of highly experienced
clinicians will demonstrate the latest, evidence based
interventions related to intraosseous needle placement. These
interactive sessions will help educate clinicians from around the
globe, advancing clinical practice and improving patient
outcomes.
During SMACC, Teleflex will also focus on the new LMA®
Protector™ Laryngeal Mask Airway. The LMA® Protector™ Airway
represents a new chapter in Teleflex’s search for the optimum
subglottic airway. With a fully silicone construction, Cuff Pilot™
Technology, dual gastric channels and the ability to intubate, the
LMA® Protector™ Airway is the most advanced second generation
airway from Teleflex.
When IV drug delivery is less than ideal, the LMA® MAD Nasal™
Device2 from Teleflex can come to the rescue delivering safe,
painless and rapidly effective treatment. No needle. No trauma. No
risk of needle stick injury. In addition, Teleflex will introduce a
range of laryngoscopes featuring the TruLite Secure™ Single-Use
Laryngoscope blade and handle, complementing our existing
Anaesthesia portfolio to offer complete airway solutions.
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed
to improve the health and quality of people’s lives. We apply
purpose driven innovation – a relentless pursuit of identifying
unmet clinical needs – to benefit patients and healthcare
providers. Our portfolio is diverse, with solutions in the fields
of vascular and interventional access, surgical, anesthesia,
cardiac care, urology, emergency medicine and respiratory care.
Teleflex employees worldwide are united in the understanding that
what we do every day makes a difference. For more information,
please visit teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®,
Pilling®, Rusch® and Weck® – trusted brands united by a common
sense of purpose.
Forward-Looking Statements
Any statements contained in this press release that do not
describe historical facts may constitute forward-looking
statements. Any forward-looking statements contained herein are
based on our management's current beliefs and expectations, but are
subject to a number of risks, uncertainties and changes in
circumstances, which may cause actual results or company actions to
differ materially from what is expressed or implied by these
statements. These risks and uncertainties are identified and
described in more detail in our filings with the Securities and
Exchange Commission, including our Annual Report on Form 10-K.
Teleflex, the Teleflex logo, Arrow, Deknatel, EZ-IO, Hudson RCI,
LMA, LMA Protector, MAD Nasal, Pilling, Rusch, TruLite Secure and
Weck are trademarks or registered trademarks of Teleflex
Incorporated or its affiliates, in the U.S. and/or other countries.
© 2016 Teleflex Incorporated. All rights reserved.
References:
1Von Hoff DD , Kuhn JG, Burris HA, Miller LJ. Does intraosseous
equal intravenous? A pharmacokinetic study. Amer J Emerg Med
2008;26:31-8
2For use with drugs approved for intranasal delivery
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160610005037/en/
Teleflex IncorporatedJake ElguiczeTreasurer and Vice President,
Investor Relations610-948-2836orMartina Teichmann-ZindlerDirector
Marketing Communications International+49
(0)7151-406-538martina.teichmann@teleflex.com
Teleflex (NYSE:TFX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Teleflex (NYSE:TFX)
Historical Stock Chart
From Apr 2023 to Apr 2024